Jan 23 (Reuters) - Australian Pharmaceutical Industries (API) (API) expects to sign a deal to commence due diligence in its takeover bid for Sigma Healthcare (SIG) , the drug distributor's chairman said on Wednesday.
In early December, API had offered to buy Sigma for A$727 million ($518.57 million), where shareholders of the pharmacy operator would receive 0.31 API shares and A$0.23 cash for each of their shares.
"We anticipate signing a non-disclosure agreement shortly that will then allow a due diligence process to commence," Chairman Mark Smith said. ($1 = 1.4019 Australian dollars)
News: SIG Australian Pharmaceutical Industries expects to begin due diligence in Sigma takeover bid
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
0.485(24.9%) |
Mkt cap ! $2.300B | |||
| Open | High | Low | Value | Volume |
| $2.52 | $2.70 | $2.32 | $138.1M | 55.83M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 123400 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.44 | 1365 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| SIG (ASX) Chart |
